Cycle Venture Asset Management
Venture Capital Exempt reporting adviser
Legal name: Cycle Venture Asset Management LLC
AUM
$39.9M
Private fund assets
Private funds
11
Venture Capital 11
Private fund assets
$39.9M
Gross asset value
Employees
—
Last Form D raise
Jul 2023
Most recent fund filing
From SEC Form ADV filing (filed Mar 20, 2026). View on SEC
People(3)
Owners and executive officers named on the firm's SEC Form ADV.
A
Member of Filing Adviser; Member and Vice President of General Partner
F
Managing Member of Filing Adviser; Member and President of General Partner
M
Member of Filing Adviser; Member and Vice President of General Partner
Funds(11)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Cycle Venture Partners Fund I LP - Cytoveris Series 4 | Venture Capital | $500K | $535K | 7 | Jul 2023 | Cold |
| Cycle Venture Partners Fund I LP - Lumeda Series 3 | Venture Capital | $1.3M | — | — | Jul 2022 | Cold |
| Cycle Venture Partners Fund I LP - Cytoveris Series 3 | Venture Capital | $2.2M | $3.5M | 11 | Nov 2021 | Cold |
| Cycle Venture Partners Fund I LP - Lumeda Series 2 | Venture Capital | $800K | $2.0M | 8 | Feb 2021 | Cold |
| Cycle Venture Partners Fund I LP - Cybrexa Series 4 | Venture Capital | $17.4M | $3.5M | 13 | Jan 2021 | Cold |
| Cycle Venture Partners Fund I LP - Lumeda Series 1 | Venture Capital | $300K | $436K | 12 | Jun 2020 | Cold |
| Cycle Venture Partners Fund I LP - Cytoveris Series 2 | Venture Capital | $800K | $2.8M | 13 | May 2020 | Cold |
| Cycle Venture Partners Fund I LP - Cybrexa Series 3 | Venture Capital | $7.1M | $5.2M | 12 | Feb 2020 | Cold |
| Cycle Venture Partners Fund I LP - Cybrexa Series 2 | Venture Capital | $5.4M | $2.1M | 6 | Jun 2017 | Cold |
| Cycle Venture Partners Fund I LP - Cybrexa Series | Venture Capital | $3.1M | $2.1M | 6 | Jun 2017 | Cold |
| Cycle Venture Partners Fund I LP - Cytoveris Series 1 | Venture Capital | $1.0M | $2.1M | 6 | Jun 2017 | Cold |
Board seats
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
No board seats matched from SEC filings yet.
Regulatory identifiers
- CRD number
- 288374
- SEC file number
- 802-124702
Sources
- SEC Form ADV Oct 14, 2026